Surgical Robots Market Innovations Enhancing Clinical Workflow Efficiency

The global surgical robots market was valued at USD 6.6 billion in 2025 and is projected to reach USD 18.5 billion by 2033, expanding at a CAGR of 13.5% from 2026 to 2033. Market growth is being driven by the increasing shortage of physicians and surgeons worldwide, coupled with the growing adoption of automated surgical instruments and robotic-assisted surgical systems. These technologies are helping healthcare providers improve surgical precision, reduce recovery times, and enhance patient outcomes, thereby accelerating demand across healthcare facilities.

Key Market Trends & Insights

  • North America accounted for the largest share of the global surgical robots market, representing 51.3% of total revenue in 2025.
  • The U.S. market remained the dominant contributor within North America during 2025.
  • By component, the instruments & accessories segment held the largest market share and is anticipated to register the fastest growth throughout the forecast period.
  • By application, the orthopedics segment captured the highest revenue share of 19.8% in 2025, supported by increasing joint replacement procedures.
  • By end-use, the inpatient segment accounted for the largest share of the market in 2025.
  • Asia Pacific is expected to emerge as the fastest-growing regional market over the forecast period due to expanding healthcare infrastructure and increasing investments in advanced medical technologies.

Market Size & Forecast

Metric

Value

Market Size (2025)

USD 6.6 Billion

Projected Market Size (2033)

USD 18.5 Billion

CAGR (2026-2033)

13.5%

Largest Regional Market (2025)

North America

Fastest-Growing Region

Asia Pacific

The market continues to benefit from rapid technological advancements in robotic-assisted surgery, including improved visualization systems, enhanced surgical navigation, artificial intelligence integration, and more precise robotic instruments. In addition, growing investments from both regional and international stakeholders are supporting research, product development, and commercialization efforts across the industry.

Download a free sample copy of the Surgical Robots Market report to understand detailed coverage and inclusions in the final report

Another major growth factor is the rising prevalence of chronic and age-related conditions that require surgical intervention. Orthopedic procedures, particularly knee and hip replacement surgeries, are creating substantial demand for robotic-assisted systems. According to the American College of Rheumatology, as of March 2025, more than 790,000 knee replacement surgeries and approximately 544,000 hip replacement surgeries are performed annually in the United States. The number of these procedures is expected to increase steadily as the aging population grows, further strengthening demand for surgical robotics solutions.

Healthcare providers are increasingly adopting robotic platforms to improve procedural efficiency, minimize surgical complications, and support minimally invasive techniques. These advantages are encouraging hospitals and surgical centers to invest in advanced robotic systems, contributing to long-term market expansion.

Looking for more specific insights? Customize this report to suite your business needs

Key Surgical Robotics Company Insights

Leading participants in the surgical robots market are actively implementing strategic initiatives to strengthen their competitive positions. These strategies include product portfolio expansion, technological innovation, partnerships and collaborations, mergers and acquisitions, and geographic expansion. Companies are also investing in research and development to introduce next-generation robotic platforms capable of addressing a broader range of surgical applications.

Growing competition among established manufacturers and emerging innovators is expected to accelerate technological advancements and improve accessibility to robotic-assisted surgery across global healthcare systems.

Explore Grand View Horizon to see global and regional level statistics related to the Surgical Robots Market

Key Surgical Robots Companies

Major companies operating in the global surgical robots market include:

  • Intuitive Surgical
  • Medrobots Corporation
  • Medtronic
  • Renishaw plc
  • Smith & Nephew
  • Stryker Corporation
  • THINK Surgical, Inc.
  • Transenterix (Asensus Surgical, Inc.)
  • Zimmer Biomet
  • MOON Surgical
  • Johnson & Johnson

Conclusion

The surgical robots market is experiencing strong growth, driven by increasing demand for minimally invasive procedures, advancements in robotic technology, and a growing shortage of healthcare professionals. Rising volumes of orthopedic surgeries, particularly knee and hip replacements, continue to create significant opportunities for robotic-assisted surgical systems. With North America maintaining market leadership and Asia Pacific emerging as the fastest-growing region, the industry is expected to witness sustained expansion through 2033. Continued innovation, strategic collaborations, and investments from key market players will remain critical factors shaping the future of the global surgical robots market.

Looking for a report customized to your requirements? Explore our Custom Research Offering

Grand View Research offers

  • Focused market intelligence reports on specific geographies or high-growth segments.
  • Extended forecast timelines for long-term planning.
  • Competitor Benchmarking and Supply Chain Analysis
  • Inclusion of regulatory and policy assessments.
  • Inclusion of custom data models, KPIs, or applications unique to your business
  • Specific high-impact Data Decks and Tables to support effective decision making

And much more…

Browse our new services – Grand View Brainshare


Comments

Post a Comment

Popular posts from this blog

Mobile Device Management Market Thrives with Growth in Cloud-Based Solutions

  According to a recent report by Grand View Research, Inc., the global   mobile device management (MDM) market   is projected to reach USD 28.37 billion by 2030, expanding at a CAGR of 24.5% from 2025 to 2030. This growth is primarily attributed to the increasing use of mobile devices in the workplace and the growing need to manage and secure them effectively. As smartphones, tablets, and other mobile devices become more prevalent, employees are increasingly using their personal devices for work—an approach known as Bring Your Own Device (BYOD). This trend is contributing to the rising number of mobile devices requiring centralized oversight and protection. MDM solutions offer organizations a unified platform to oversee and secure mobile devices, enabling functions such as security policy enforcement, device usage monitoring, and remote data wiping in cases of loss or theft. As companies continue to implement BYOD strategies or issue corporate devices to employees, deman...
Read more

U.S. Interventional Oncology Market Boosted by Aging Population

  The   U.S. interventional oncology market   size was estimated at USD 998.4 million in 2024 and is projected to reach USD 1,597 million by 2030, expanding at a CAGR of 8.17% from 2025 to 2030. This market growth is primarily driven by the increasing prevalence of cancer, continuous technological advancements in minimally invasive treatments, expanding investments in interventional oncology, and the aging population across the U.S. A major contributing factor is the rising incidence of cancer in the country. According to the American Cancer Society, approximately 2,041,910 new cancer cases are expected to be diagnosed in the U.S. in 2025, with 618,120 projected cancer-related deaths. As conventional therapies like chemotherapy and radiation often lead to significant side effects, minimally invasive techniques such as radiofrequency ablation and microwave ablation are becoming more popular. These procedures target tumors precisely while minimizing harm to surrounding tiss...
Read more

HLA Typing Market Fueled by Growing Prevalence of Autoimmune Disorders

  The global   HLA typing market   was valued at USD 1,032.1 million in 2022 and is anticipated to reach USD 1.7 billion by 2030, growing at a compound annual growth rate (CAGR) of 6.7% from 2023 to 2030. This market growth is primarily driven by the increasing need for organ transplantation and the extensive application of human leukocyte antigen (HLA) testing in pharmacogenetics. HLA matching remains a critical method for evaluating tissue compatibility in transplantation. It is a mandatory procedure for all organ donors, whether the organs are from deceased individuals, relatives, or unrelated donors. Accurate HLA matching significantly reduces the risk of post-transplant complications. The demand for organ transplants has risen steadily over time. As reported by the Organ Procurement and Transplantation Network, 41,354 organ transplants were performed in the United States alone in 2021—a 5.9% increase compared to 2020. Kidney transplants were the most common, with 24,...
Read more